Le Berre, C.; Degrendel, M.; Houard, M.; Benetazzo, L.; Vachée, A.; Georges, H.; Wallet, F.; Patoz, P.; Bortolotti, P.; Nseir, S.;
et al. Optimizing Antibiotic Treatment Duration for ESBL-Producing Enterobacteriaceae Bacteremia in ICU: A Multicentric Retrospective Cohort Study. Antibiotics 2025, 14, 358.
https://doi.org/10.3390/antibiotics14040358
AMA Style
Le Berre C, Degrendel M, Houard M, Benetazzo L, Vachée A, Georges H, Wallet F, Patoz P, Bortolotti P, Nseir S,
et al. Optimizing Antibiotic Treatment Duration for ESBL-Producing Enterobacteriaceae Bacteremia in ICU: A Multicentric Retrospective Cohort Study. Antibiotics. 2025; 14(4):358.
https://doi.org/10.3390/antibiotics14040358
Chicago/Turabian Style
Le Berre, Camille, Maxime Degrendel, Marion Houard, Lucie Benetazzo, Anne Vachée, Hugues Georges, Frederic Wallet, Pierre Patoz, Perrine Bortolotti, Saad Nseir,
and et al. 2025. "Optimizing Antibiotic Treatment Duration for ESBL-Producing Enterobacteriaceae Bacteremia in ICU: A Multicentric Retrospective Cohort Study" Antibiotics 14, no. 4: 358.
https://doi.org/10.3390/antibiotics14040358
APA Style
Le Berre, C., Degrendel, M., Houard, M., Benetazzo, L., Vachée, A., Georges, H., Wallet, F., Patoz, P., Bortolotti, P., Nseir, S., Delannoy, P.-Y., & Meybeck, A.
(2025). Optimizing Antibiotic Treatment Duration for ESBL-Producing Enterobacteriaceae Bacteremia in ICU: A Multicentric Retrospective Cohort Study. Antibiotics, 14(4), 358.
https://doi.org/10.3390/antibiotics14040358
